BASF Plans Worldwide Expansion of PVP Production
BASF plans to invest up to €56 million in the expansion of its Polyvinylpyrrolidone (PVP) value chain over the next 4 years. PVP is a polymer which is used in diverse industries, including the pharmaceutical or the personal care sector, mainly due to its binding properties. Through revamping existing plants in Ludwigshafen, Germany and Geismar, Louisiana and introducing the PVP technology at BASF’s site in Shanghai, China, the company will increase its global PVP production capacities by up to 6000 metric tons. All plants will operate under the highest possible quality standards (current Good Manufacturing Practice). BASF is the inventor and one of the market leaders for PVP.
“Our global production network and technology leadership enable us to obtain the highest levels of supply reliability and quality for our customers in multiple industries,” said Michael Heinz, Member of the Board of Executive Directors, BASF SE. “With this investment we are actively participating in the strongly growing PVP market, especially within the pharmaceutical industry,” added Saori Dubourg, President of BASF’s Nutrition & Health division.
The polymer PVP can be used in a broad range of applications due to its varied features: It is water soluble, but can also absorb large quantities of water; it is non-irritant to the skin and does not pose a health hazard; it is temperature-resistant, pH-stable, non-ionic and colorless. A majority of BASF’s PVP capacities are destined for the pharmaceutical industry. Under the name Kollidon, PVP is mainly used as an excipient in tablets with binding and disintegrant functionality. As a binder, it enables the individual active ingredients of a tablet to form a homogenous entity and as a disintegrant it ensures that the tablets break up in liquid and release the active ingredient quickly. The excipient can furthermore be deployed as lyophilisation agent, suspension stabilizer and thickener.
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance